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Cardiac magnetic resonance (CMR) imaging has been widely used to assess myocardial
perfusion and scar and is the non-invasive gold standard for identification of focal
myocardial fibrosis. However, the late gadolinium enhancement technique is limited in
its accuracy for absolute quantification and assessment of diffuse myocardial fibrosis by
technical and pathophysiological features. CMR relaxometry, incorporating T1 mapping,
has emerged as an accurate, reproducible, highly sensitive, and quantitative technique
for the assessment of diffuse myocardial fibrosis in a number of disease states. We
comprehensively review the physics behind CMR relaxometry, the evidence base, and
the clinical applications of this emerging technique.
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Cardiac magnetic resonance (CMR) imaging has been used widely to assess myocardial perfusion
and scar (1–5). It is the non-invasive gold standard for left and right ventricular quantitation, as
well as the assessment and quantitation of focal myocardial fibrosis (after infarction or due to other
causes of cellular injury). Myocardial necrosis causes high signal on late gadolinium enhancement
(LGE) inversion recovery (IR) T1-weighted images with excellent signal-noise ratios, and this has
become the reference standard for non-invasive scar imaging in cardiomyopathies of various causes
(1–4). However, LGE is limited in its ability to assess and quantitate diffuse (non-focal) myocardial
injury and fibrosis. LGE is affected by inconsistencies in acquisition parameters, such as choice
inversion time (TI), and in post-processing when signal intensity (SI) thresholds may be arbitrarily
applied to distinguish normal myocardium from fibrotic tissue (6, 7). Moreover, the critical issue
with LGE is that SI is expressed on an arbitrary scale (relative SI compared to “nulled” normal
myocardium). Imaging of myocardial fibrosis using relative differences between scar and normal
myocardium tissue is therefore qualitative. Semi-quantitative analysis of LGE can be performed
using signal thresholding applied to LGE images; however, there are differences in technique for
infarct quantitation (8), and this is only relevant when regional scar/enhancement is present; it does
not allow quantitation of diffuse interstitial fibrosis.
Thus, in non-ischemic cardiomyopathies, such as hypertension or diabetes, LGE CMR is unable
to detect signal differential where the collagen deposition is diffuse and widespread throughout the
myocardium (9).
CMR RELAXOMETRY
Cardiac magnetic resonance is an evolving technique, providing valuable and comprehensive data
on the anatomy and functional integrity of both the heart and coronary blood vessels. Currently,
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CMR is performed at magnetic field strengths of 1.5 or 3 T. MR
images generate by exploiting the magnetic property (called spin)
of nuclei that have an odd atomic number or mass number (10).
A proton generates a small magnetic field much like a bar mag-
net, because the proton has mass, a positive charge, and spins.
This small magnetic field is referred to as its magnetic moment.
The single proton of the hydrogen molecule gives it a significant
magneticmoment and combinedwith its abundance in the human
body, makes it an ideal marker for clinical MRI.
In the absence of an applied magnetic field, the magnetic
moments of the hydrogen nuclei are oriented randomly; when
placed in a high static magnetic field (B0) they will align either
parallel or anti-parallel to the magnetic field. Spins that aligned
parallel to B0 have a lower energy than those aligned anti-
parallel, and therefore more align parallel creating a net magne-
tization (M0) of the sample in the direction of the magnetic field
B0 (11).
Larmor Equation
The interaction of a magnetic moment with B0 causes the mag-
netic moment to precess about the axis of the static magnetic field
(B0), at a frequency specific to the strength of (B0)— the Larmor
frequency. The Larmor frequency is defined as follows:
ν= γ2πB0;
where ν is the frequency, in megahertz, B0 is the strength of
the magnetic field, γ is the gyromagnetic ratio for hydrogen, and
γ/2π= 42.57MHz/T (11).
When a radio frequency (RF) pulse at the Larmor frequency
is applied to the nuclei within the magnetic field, nuclei begin
to resonate and those in the lower energy state absorb energy.
Depending on the RF pulse length, the precession of affected
nuclei will be moved into the transverse magnetization plane (xy
axis) and be in phase. With cessation of the RF field, the nuclei
will realign to their original orientation parallel to B0—a process
referred to as relaxation. During the relaxation process, the net
relaxation induces an RF signal, at the characteristic frequency,
which can be measured by a receiver coil. This signal is known as
free induction decay (FID).
MRI Relaxation Time
Three different properties of the interaction of the magnetic
moments with B0 can be measured. These are the longitudinal
time constant T1, or “spin-lattice” relaxation, and transverse time
constant T2, or “spin–spin” relaxation and T 2 , which is governed
by a combination of the effect of spin–spin relaxation, and the
homogeneity of the magnetic field. These constants are param-
eters that are used in MRI to distinguish between normal tissue
types and pathological process. The SI of these times depends
on the technical parameters that are used for image acquisition
(12, 13) and the magnetic properties of a given tissue (14). At a
given magnetic field strength, each tissue has a normal range for
relaxation time. So, the variation of relaxation time from their
normal value can be used to identify pathological process (e.g.,
edema and scar tissue).
FIGURE 1 | T2 and T2* curve. The T2* has shorter time than T2 time. T2*
exponential decay (30–100ms, and shorter for higher B0).
T1 relaxation time refers to the tissue-specific time constant and
is a measure of the time taken for protons to realign with the static
field after perturbation by the RF pulse. This realignment with B0
is termed T1 longitudinal relaxation and the time in milliseconds.
The above diagram T1 recovery curves demonstrate the fat has
shorter T1 times than water molecules. This results from the fact
that the fat nuclei lose their energy to lattice quickly, due to slow
molecular motion, giving a relatively shorter T1 time. The quicker
the system returns to the equilibrium state, such as occurs in fat,
the greater the magnetization available to be excited by the next
imaging pulse, producing more signals. Thus, fat appears bright
in T1-weighted image (11).
T2 relaxation causes decay of signal arising from the dephas-
ing of nuclear precession and consequent loss of net coherence
(Figure 1) (15). T2 decay due to the magnetic interaction that
occurs between protons, results in an exponential decay of the
transversemagnetization vector, also governed by tissue structure.
Unlike T1 relaxations, T2 does not involve a transfer of energy but
only a change in phase. The water molecules have a long T2 decay
and appear brighter in T2-weighted images due to the property
that more rapidly moving molecules have a lower tendency to
transfer their spin leading to a slower dephasing of the transverse
magnetization.
A third decay parameter, T 2 , describes the decay of transverse
magnetization, due to spin–spin relaxation (T2), together with
inhomogeneity in the static magnetic field (ΔB0), which occurs at
tissue interfaces. This leads to amore rapid loss of phase coherence
and the MR signal. These relaxation times are influenced by
several factors, including field strength, blood iron content, blood
volume, temperature, and blood oxygenation (15).
MYOCARDIAL T1 MAPPING IN THE
SETTING OF MYOCARDIAL FIBROSIS
The conventional T1 mapping method can be generated with an
inversion recovery spin echo (IR-SE) sequence. Spin echo uses a
180°RF pulse to invert the spins within the selected slice, followed
by a 90°RF pulse rotate the recovered magnetization at TI into
the transverse plane, and a further 180° RF pulse to form the
spin echo (12). Sampling of IR curve repeats multiple times with
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different TIs. The repetition time (TR) of the sequence must be
long enough for recovery longitudinal magnetization before the
next 180°inversion pulse. The SI of the final image is proportional
to the relaxed fraction of the magnetization during the TI as
follows:
SI = CM0 exp

 TET2

1  2 exp

 TIT1

;
where the first exponential term relates to signal decay due to
transverse relaxation (during TE), the second exponential refers
to T1 relaxation (during TI). IR-SE is a gold standard to estimate
T1 with a good accuracy. However, the drawback of IR-SE is that
the TR of the sequence should be very long, i.e., TR should be
at least five times longer T1 to allow full recovery of longitu-
dinal magnetization. To reduce the acquisition time, inversion
recovery turbo spin echo is currently used for routine clinical
purposes (12).
On traditional T1-weighted images, the focal differences in T1
signal are measured qualitatively, assessed by visual inspection
using relative units, and cannot be consistently compared between
scans (16). Formore precisemeasurement, an emerging technique
for CMR T1 mapping has been applied to measure myocardial
signal (in milliseconds) directly on a standardized scale within a
single breath hold. This quantification of T1 mapping provides a
benefit over the T1-weighted imaging of the myocardium by giv-
ing a quantitativemeasure of T1 time frommultiple scans. A para-
metric map can be then reconstructed by calculating T1 values
on a pixel-by-pixel basis (17), so, pixel intensities correspond to
T1 values. Different cardiac MR acquisition sequences have been
applied to create myocardial T1 maps, including Look–Locker
(LL) and modified Look–Locker inversion recovery (MOLLI)
(9, 16, 18–24).
T1 Mapping Using the LL Technique
The most common technique to measure spin-lattice T1 relax-
ation time values is the eponymously named “LL” sequence (also
known as “TI scout”). It has been widely used to estimate the
optimal TI for assessment of myocardial LGE (23, 25). It was
originally proposed by Look and Locker in 1968 and developed
more fully in 1970 (24). It consists of an initial inversion pulse,
followed by a train of pulses with a constant, limited flip angle
(7–15°). The inversion pulse prepares the longitudinal magne-
tization, which then recovers exponentially according to the T1
(24). The experiment is repeated until the k-space Cartesian map
of data is filled, allowing an image to be reconstructed. By pro-
ducing a train of absorption or dispersion signals (continuous
wave magnetic resonance) or FIDs (pulsed magnetic resonance),
it is possible to save time in spin-lattice relaxation measurements
due to the fact that it is not necessary to wait for equilibrium
magnetization before initiating the train (24) (see Figure 2). The
total time required to acquire T1 would be significantly reduced
compared to IR because the LL technique allows for multiple of
MZ in a single measurement period (TM).
It was co-opted by Kaptein et al. in 1976 to quickly sample the
recovery after a preparation pulse, during the recovery period or
transient phase (27). This method was developed into the T one
by multiple readout pulses (TOMROP) imaging sequence (28).
In TOMROP, the multiple samples of a particular recovery after
RF preparation each correspond to separate image. To acquire
a complete data set for each image, the whole sequence must
be repeated numerous times. Each repetition fills the next line
of k-space for each image, and so on. Each image has a unique
delay time. Early LL-based T1 techniques required the return to
equilibriumof the spin system before the next application of an RF
preparation pulse. Consequently, the acquisition time per slice of
such implementations was long (28). Hinson and Sobol (29) used
FIGURE 2 | Diagram of a conventional 2D Look–Locker pulse sequence. The inversion-pulse/α-pulse train is repeated for every ky phase encode step. For N
α-pulses, a series of N images are formed corresponding to times TIn = td + (n 1)τ(n+1, 2, : : :,N) after the inversion pulse, where td is the time between the
inversion pulse and the first α-pulse (26).
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an LL method with no preparation pulse but the method suffered
from poor accuracy, attributed to the slice profile. The late 1980s
and early 1990s saw the LLmethod used forT1 measurements in a
number of publications. Crawley and Henkelman (30) compared
a number of one-shot and IR methods (LL, saturation recovery,
IR, and stimulated echo) and concluded that the LL method was
almost as efficient (in terms of dynamic range of the data and
the proportion of the imaging time used to sample MR signals)
as IR. Brix and colleagues used the TOMROP method with 32
gradient echoes to test for non-exponential behavior, found in
fatty tissues (31), in a total acquisition time of 4min. The LL
single-shot IR method has been optimized and refined (32, 33)
including improved RF preparation pulses (34, 35).
Echo-planar imaging (EPI) was incorporated into the IR LL-
basedmethod (36), by interleaving EPI readouts for eight different
slices after an inversion pulse. The sequence was repeated, and the
slice order was changed to achieve a range of TIs for each slice,
with a total acquisition time of 30 s. LL with EPI was later applied
in vivo in less than 3 s (37), using amodified blippedEPI technique
(38), sacrificing and accuracy to some extent. An entire image
was acquired at each point on a single recovery of longitudinal
magnetization after a saturation pulse. The technique was opti-
mized in 1998 (39) and has found applications in pharmacokinetic
modeling (25).
The development of LL technique, which is available on Philips,
GE, and Siemens platforms, is summarized in Table 1.
The LL sequence has been widely applied in CMR due to its
fast acquisition with minimal breath-hold requirements. The LL
sequence has been used to measure T1 values in patients with
myocardial fibrosis (23). However, it suffers from significant lim-
itations: low flip angle RF pulse exciting the magnetization and
the two RR intervals in the LL sequence are not sufficient for
the magnetization to return to equilibrium. This causes under-
estimation of true T1 values using LL. Furthermore, the LL T1
images with different TIs are acquired at different cardiac phases.
Therefore, images are “cine” with cardiac motion effect, which
requires tedious manually tracking of the myocardial borders for
each phase, a labor-intensive and error-prone process which will
is challenging in clinical practice. The drawing of regions of inter-
est (ROI) in myocardial segments requires adjusting for cardiac
motion, which result in including blood pool (partial volume
averaging) and artificially increasing the measured T1 (40). T1
times between patients may vary due to differences in Gd kinetics
(such as in renal impairment), or with different contrast agents;
correction factors have been proposed using kinetic modeling for
the LL technique (41).
To address these shortcomings, several myocardial T1 mapping
sequences have been created, including MOLLI.
T1 Mapping with MOLLI
Currently, the most evaluated sequence for myocardium T1 map-
ping is an MOLLI sequence (22, 42). The T1 mapping identifies a
significant variation between normal and abnormal myocardium.
It demonstrates that the myocardial fibrosis among differ-
ent myocardial disorders includes ischemia (18), acute/chronic
infraction (19), amyloidosis (20), diabetic (21), dilated and hyper-
trophic cardiomyopathy (17), and heart failure (9).
TABLE 1 | Summary of development of Look–Locker (LL) technique.
Reference Summary of research findings
Look and Locker (24) Initial proposition of LL technique
Look and Locker (24) Fully analyzed NMR pulse sequence to measure
a spin-lattice T1 relaxation time
Kaptein et al. (27) LL was co-opted to quickly sample the recovery
after a preparation pulse during the recovery
period
Gerumann (28) T one by multiple readout pulses (TOMROP)
was proposed in which the multiple samples of
a particular recovery after radio frequency (RF)
preparation each corresponds to separate
image
Hinson and Sobol (29) LL method was applied without preparation
pulse
Crawley and Henkelman (30) Compared [LL, saturation recovery, inversion
recovery (IR), and stimulated echo] and
concluded that LL was almost as efficient
Brix et al. (31) TOMROP was used with 32 gradient echoes in
a total acquisition time of 4min
Kay and Henkelman (32) LL single-shot IR method has been optimized
and refined
Gowland and Leach (33) LL single-shot IR method has been optimized
and refined
Been et al. (34) Improved RF preparation pulses
Gowland et al. (35) Improved RF preparation pulses
Ordidge et al. (36) Echo-planar imaging (EPI) was incorporated
into the IR LL-based method
Gowland and Mansfield (37) EPI was applied in vivo in less than 3 s
Freeman et al. (39) An entire image was acquired at each point on
a single recovery of longitudinal magnetization
after a saturation pulse
Karlsson and Nordell (25) EPI with LL method has found application in
pharmacokinetic modeling in the head
Daniel et al. (40) Modified Look–Locker inversion recovery
(MOLLI) is proposed to overcome the limitations
of the conventional LL approach for cardiac
applications
Daniel et al. (22) Studied the single breath-hold myocardial MR
T1 mapping with MOLLI technique with high
spatial resolution at 1.5 T MR reproducibility
study
Daniel et al. (58) Investigated optimization and validation of a fully
integrated pulse sequence for (MOLLI) T1
mapping of the heart
Iies et al. (9) Evaluation of diffuse myocardial fibrosis in heart
failure with cardiac magnetic resonance
contrast-enhanced T1 mapping
Modified Look–Locker inversion recovery is a CMR pulse
sequence that is used for accurate T1 mapping of myocardium
with high spatial resolution. A T1 map of the myocardium is a
reconstructed image, where the T1 relaxation value is computed
for every pixel of the corresponding myocardial voxel. Signal
recovery from each myocardial voxel is acquired at different TIs
following a single inversion pulse, all gated to the same car-
diac phase, thereby enabling a pixel-based T1 quantification in
the myocardium. MOLLI has introduced two variations to the
standard LL sequence; selective data acquisition at a given time
of the cardiac cycle over successive heartbeats, and merging of
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image sets from multiple LL experiments with varying TIs into
one data set (22, 40). While selective data acquisition effectively
decreases the number of images acquired in each LL experi-
ment to one per heartbeat, the use of multiple LL experiments
with different TIs increases the number of samples of the relax-
ation curve to a value that is sufficiently high for accurate T1
estimation.
Modified Look–Locker inversion recovery is an ECG-gated
pulse sequence scheme and uses three prepared LL experiments
consecutively within one breath hold over 17 heartbeats to recon-
struct 11 images with different TIs. Three successive ECG-
triggered LL experiments (LL1, LL2, and LL3) are carried out
with three, three, and five single-shot readouts, respectively, at
end diastole of consecutive heartbeats to sample the recovery
of longitudinal magnetization after the inversion pulse. MOLLI
pulse sequence scheme is illustrated (Figure 3). T1 maps can be
generated any time before or after contrast agent (e.g., gadolin-
ium) administration (40).
Reconstruction of T1 maps from MOLLI source images is
performed offline using purpose written customized software,
or inline using vendor-specific processing, with ROI (septal or
endo–epicardial) able to be analyzed in a pixel-wise quantitative
fashion (Figure 4).
Image data are sorted by their effective TI, which are given by
t = TI+ (n  1)RR;
FIGURE 3 |Modified Look–Locker inversion recovery pulse sequence scheme. There are three Look–Locker (LL) experiments, each prepared by a separate
180°inversion pulse (“inv”). The first is defined as TIminimum, and then TI of the second and third LL experiments is determined by TIminimum TIincrement and
TIminimum 2TIincrement. After inversion pulses, readout is in a non-segmented fashion with a single flip angle (α). A defined pause of a certain number of R–R intervals
allows for signal recovery (40).
FIGURE 4 | T1 map of a healthy volunteer: using 17 heartbeats to reconstruct 11 images with different inversion times (TIs) at end of diastole phase.
By merging these images into one data set, T1 values are computed for every pixel with three parameter curve fitting (39, 41). A reconstructed T1 map with
parametric color scale is produced for these pixel values, and the segmental and global T1 times can be estimated.
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where N= image number within the LL experiment and
RR= heartbeat interval. Three-parameter non-linear curve fitting
using a Levenberg–Marquardt algorithm is performed for corre-
sponding pixel, which is given by
y = A  B exp

  tT 1

;
where y denotes SI and T 1 corresponds to the apparent, modified
T1 in an LL experiment.
Correction for readout-induced attenuation of the relaxation
curve is attempted by using the three-curve fitting parameters
T 1 , A, and B for the calculation of T1. Then, T1 estimates as in
conventional LL methods by
T1 = T 1

B
A   1

;
The MOLLI sequence has been fully described, optimized,
tested/re-tested, in phantoms and in large cohorts of healthy
volunteers (22, 40) as well as being applied in cardiomyopathies
(9, 17, 18, 20, 43). In addition, the T1 mapping with MOLLI has
been validated against histopathology for assessment of myocar-
dial fibrosis. It demonstrated that the pre-contrast “native T1”
has a linear correlation with percentage of myocardial fibrosis as
measured histologically on invasive myocardial biopsy. T1 times
post-contrast administration (10–15min) had an inverse linear
relationship with collagen content in myocardial fibrosis subjects
(9, 44, 45).
Nacif et al. (46) compared n= 168 myocardial T1 maps using
LL and MOLLI at 1.5 T, showing that pre-contrast (native) T1
values had good agreement, but LL had wider limits of agree-
ment, and post-contrast T1 maps also had good agreement but
with LL giving higher values than MOLLI, hence they are not
interchangeable (46).
T1 mapping can be generated for different segments of the
myocardium (base, mid-cavity, and apex) within a single breath
hold of about 15–20 s. However, the apex T1 values with MOLLI
are slightly higher than basal andmid-cavity. The increasing in T1
values may be caused by partial volume effect and some degree of
overestimation effect in apical level of left ventricle. These effects
occur as a result of the ventricular wall being somewhat tilted
toward the apex and no longer being aligned perpendicular to the
short axis images (47–49).
Furthermore, T1 mapping with MOLLI has a greater repro-
ducibility, accuracy, and an excellent overall inter- and intraob-
server agreement over a wide range of TIs in pre- and
post-contrast agent administration compared to the LL technique
(22, 42). However, the T1 mapping with MOLLI sequence is
sensitive to extremes of heart rate (bradycardia or tachycardia)
(22) leading to slightly underestimation of T1 values. This may
be corrected though “heart rate correction” by changing in the
timing of the readouts with respect to the inversion pulses at
different heart rates. This variation introduces various degrees of
disturbance of the T1 relaxation curve. The heart rate affects the
T1 value if the T1 value is higher than 750ms or less than 200ms
with MOLLI (22, 42).
Moreover, MOLLI is limited by long breath hold about 15–20 s
(17 heart beats to acquire the final T1 maps). This may be difficult
for elderly and pulmonary compromised patients and generates
respiratory and motion artifacts (50). However, modern inline
processing provides registration tools to reduce motion artifacts
before the computation of final T1 maps (motion corrected or
“MoCo MOLLI”). This will minimize the sensitivity of T1 map-
ping to motion artifacts and heart rate. Also, various acquisition
sequences with short breath hold, such as shortened modified
Look–Locker inversion recovery, have been validated and recently
applied for cardiomyopathies (51, 52). At 1.5 T, the pre- and post-
contrast (10min) T1 times of normal myocardium are 980 53
and 470 26ms, respectively (Figure 5) (22). Pre-contrastT1 val-
ues of myocardial fibrosis (infarction scar) are significantly longer
than those of normal myocardium (1,060 61 vs. 987 34ms)
(43). The longer pre-contrast T1 values in myocardial fibro-
sis patients have been reported in different cardiomyopathies.
FIGURE 5 | Graph shows recovery of absolute T1 (meanSD in milliseconds) at 1.5 T in mid-cavity short axis slices at pre- and post-contrast
(0–20min) after administration of 0.15mmol/kg of gadopentetate dimeglumine (22).
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Infarction, myocarditis, and interstitial diffuse fibrosis, all have
high pre-contrast T1 values when compared with normal myocar-
dial T1 times (17, 20, 43). However, longer T1 values may also be
noticed in different pathologically important processes, such as
edema (53). Previous phantom, animal, and human tissue based
studies lend insight into the effects onT1 signal by showing thatT1
increases with increased water content and amount of extracellu-
lar fibrillar macromolecules (14, 54). Messroghli et al. concluded
that increased myocardial T1 mapping corresponds to the areas
of the human myocardial infarction, which showed on LGE (43).
However, the links between the exact molecular mechanism in
healthy tissue and myocardial fibrosis and corresponding pre-
contrast T1 are less well understood. On the hand, the decrease
in post-contrast T1 values in diffuse myocardial fibrosis has been
previously related to increased extracellular space. It has been well
described in acute, chronic ischemic, diffuse myocardial fibrosis,
and inflammatory myocardial injury. The post-contrast T1 times
(10min) were significantly shorter in chronic infarct scar com-
pared with normal myocardium at 0.15mmol/kg (390 20 vs.
483 23ms, respectively) (43).
Also, T1 mapping with high magnetic field (3 T) has been
reported in a few studies of interstitial myocardial fibrosis. It was
similar to 1.5 T, the pre-contrast T1 was longer, and post-contrast
T1 was shorter inmyocardial fibrosis patients compared to normal
myocardium. Puntmann et al. (55) reported higher pre-contrast
T1 values for hypertrophic and non-ischemic-dilated cardiomy-
opathies at 3 T compared to controls (hypertrophic 1.254 43ms
and non-ischemic-dilated cardiomyopathy 1.239 57ms vs.
healthy 1.070 55ms). Also, the post-contrast T1 values (10min)
at 3 T were shorter in hypertrophic and dilated cardiomyopathies
compared to healthy (hypertrophic: 307 47ms, dilated car-
diomyopathies: 296 43ms vs. controls: 402 58ms) (55).
There are studies published for normal and diffuse myocardial
fibrosis of myocardium T1 values, as described comprehensively
in Tables 2 and 3.
The myocardium is made of densely packed myocytes, con-
tributing to approximately 90% of myocardial mass. Signal from
pre-contrast imaging reflects the majority of signal from the
myocytes themselves. Conversely, in post-contrast imaging, the
majority of Gd-based contrast signal arises from the interstitium
(as Gd is an extracellular contrast agent and does not, therefore,
reside within myocytes unless they are damaged); thus, post-
contrast T1 mainly reflects interstitial or replacement fibrosis (see
Box 1, below), hence the ability to calculate extracellular volume
(ECV) from the difference between these two parameters.
Extracellular Volume
T1 mapping data can be used to calculate ECV fraction, using
the pre- and post-contrast T1 times and hematocrit. Details of
this technique and its uses are beyond the scope of this review;
SCMR guidelines exist to guide application of T1 mapping and
ECV quantitation (65).
Limitations of T1 Mapping
Challenges remain with myocardial relaxometry for T1 mapping.
These include technical challenges such as variations of T1 times
at different field strength and across different vendors, and the
TABLE 2 | Healthy clinical studies using T1 and T2*.
Reference Sample
size
T1/T2* mapping
sequence
Result of T1 or T2* mapping
(ms)
Wacker
et al. (56)
5 srTFL, segmented
T2* gradient echo
pulse
T1= 1,21972ms
T2*=353ms
Sebastian
et al. (57)
12 LL T1= 1,033126ms
T2*=NA
Messroghli
et al. (22)
15 MOLLI T1= 98053ms
T2*=NA
Messroghli
et al. (58)
20 MOLLI T1= 93963ms
T2*=NA
Sparrow
et al. (59)
15 MOLLI T1= 98053ms
T2*=NA
Iles et al. (9) 20 VAST T1= 97562ms
T2*=NA
Li et al. (60) 13 2 echo times GRE T1=NA
T2*=336.5ms
Reeder
et al. (61)
5 Multi-echo GRE T1=NA
T2*=386ms
Anderson
et al. (62)
15 Multi-echo GRE T1=NA
T2*=5,216ms
Positano
et al. (63)
15 Multi-echo GRE T1=NA
T2*=38 9.2ms in endocardial
sectors and 33.18.4ms in
epicardial sectors
Messroghli
et al. (64)
20 Multi-echo GRE T1=NA
T2*=27.9 3.4ms in
anteroseptal and 23.15.2ms
in inferolateral
Piechnik
et al. (51)
342 shMOLLI T1= 962 25ms
T2*=NA
Heart rate only physiologic
factors effect on myocardial T1
values
NA, not applicable; srTFL, saturation recovery turboFLASH; LL, Lock–Locker; MOLLI,
modified Lock–Locker inversion recovery sequence; VAST, inversion recovery gradient
echo sequence with variable sampling of the k-space in time; GRE, gradient pulse
sequence; shMOLLI, short modified Look–Locker sequence.
rapidity in growth of pulse sequences being released as product
and as works-in-progress, calling into question both the inherent
accuracy and the level agreement between these techniques. Fur-
thermore, the variations in T1 relaxometry values with different
contrast doses and image timing require further investigation, to
establish the test–retest and inter-site reproducibility of this tech-
nique. Next, the challenges to application ofT1mapping to clinical
practice include establishment of robust normal ranges in large
cohorts across multiple ethnic groups, and the observation that
T1 mapping appears to be a highly sensitive technique, with the
ability to discriminate healthy normal myocardium and identify
very early changes in substrate. However, this technique lacks
specificity; a wide variety of conditions prolongs native T1 and/or
shortens post-contrast myocardial T1. Therefore, further clinical
data are required in order to establish the use of these parameters
in relation to disease (e.g., early detection of target organ dam-
age in systemic conditions such as hypertension or diabetes), to
inform treatment decisions, and their ability to predict or alter
clinical outcomes.
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TABLE 3 | Clinical studies using T1 mapping for myocardial diffuse fibrosis in clinical patients.
Reference Cardiac disease
category
Patient sample
size
T1 mapping
method
Summary of findings
Thuny et al. (66) Systemic sclerosis 37 Modified Look–Locker
inversion recovery (MOLLI)
LV diastolic dysfunction had a shorter 15min post-contrast
T1 time (ms) than those with a normal diastolic function
(4317 vs. 4648, p= 0.01)
Thibault et al. (67) Type II diabetic patient 24 MOLLI Mean myocardial T1 relaxation time was significantly shorter
in diabetic patients than in volunteers both at 5 (3125 vs.
3616ms, respectively, p<0.001) and 15min (4056
vs. 4565ms, respectively, p<0.001) after gadolinium
injection
Ellims et al. (68) Hypertrophy
cardiomyopathy
51 VAST Post-contrast myocardial T1 time was significantly shorter in
patients with HCM compared to controls, consistent with
diffuse myocardial fibrosis (49880 vs. 56147ms,
p<0.001)
Kammerlander
et al. (69)
Patients with NH2-terminal
portion of the precursor of
brain natriuretic peptide
(NT-proBNP)
37 N/A In patients with NT-proBNP levels >400pg/ml mean T1
was significantly shorter than in patients with NT-proBNP
<400pg/ml (374.651.1 vs. 404.634.4ms, p= 0.042)
and controls (509.446.5ms, p<0.001)
Sibley et al. (70) Non-ischemic
cardiomyopathy
73 Look–Locker (LL) 47 patients had a focal myocardial scar and 26 without scar
tissue. The midwall circumferential strain (Ecc) was reduced
(–13.05.4%), and mean T1 time was 47870ms in
patients with no scar tissue
Jellis et al. (21) Type II diabetic patients 67 VAST Subjects have a shorter post-contrast T1= 43420ms.
Post-contrast T1 was associated with echocardiography
diastolic dysfunction (Em r= 0.28, p= 0.020; E/Em
r= 0.24, p= 0.049)
Messroghli et al.
(42)
Acute myocardial infarction 8 Inversion recovery
(IR)-prepared fast gradient
echo sequence
T1 pre-contrast value of the infarcted myocardium was
significantly prolonged compared with non-infarcted normal
myocardium (+187%). T1 10-min post-contrast value of
the infarct was significantly reduced compared with normal
myocardium ( 274%)
Messroghli et al.
(43)
Acute and chronic
myocardial infarction
24 MOLLI In chronic MI, the pre-contrast T1 relaxation time of
hyper-enhanced areas was higher than T1 of remote areas
(1,06061 vs. 98734ms, p<0.0001). In acute MI, the
pre-contrast T1 value of hyper-enhanced areas was higher
than remote areas (1,19776 vs. 1,01166). The
hyper-enhanced in acute is higher than chronic infarction
Sebastian et al. (57) Acute and chronic
myocardial infarction
10 LL Mean T1 values of the normal myocardium post-contrast
was 53666ms; chronically infracted pre-contrast and
post-contrast was 1,00067 and 40843ms,
respectively
Sparrow et al. (59) Myocardial fibrosis in
chronic aortic regurgitation
8 MOLLI There is a significant difference in segmental averaged T1
relaxation between in abnormal wall motion vs. normal
control segments in 10, 15, and 20min after administration,
Gd: 510 vs. 476, 532 vs. 501, and 560 vs. 516ms,
respectively
Iles et al. (9) Chronic heart failure 25 VAST Post-contrast myocardial T1 times were shorter in heart
failure subjects than controls (38317 vs. 56423ms)
controls even when excluding areas of regional fibrosis. T1
15-min post-contrast values correlated significantly with
collagen volume fraction on myocardial biopsies (R= –0.7)
Maceira et al. (71) Cardiac amyloidosis 22 Segmented IR sequence Subendocardial T1 in amyloid patients was shorter than in
controls (at 4min: 42773 vs. 57975ms; p<0.01)
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BOX 1 | Source of T1 signal.
Pre-contrast “Native” T1=predominant signal from myocytes (replacement
fibrosis, or intracellular accumulation, e.g., Fabry disease).
Post-contrast T1=predominant signal from interstitial space (interstitial
fibrosis).
CONCLUSION
Myocardial T1 mapping using quantitative relaxometry is an
emerging and important tool in the assessment of global myocar-
dial fibrosis. It is a highly sensitive marker of disease but is
not specific, with changes in myocardial T1 occurring in many
different conditions. Nevertheless, the high sensitivity and excel-
lent reproducibility of the technique offers a tool for the early
detection of myocardial damage, over-and-above techniques such
as the CMR LGE technique and other modalities such as speckle
tracking echocardiography, pulse wave velocity, and tissue tag-
ging. Native T1 mapping is proving to be a robust indicator of
early myocardial disease in many conditions, and normal ranges
and guidelines for post-processing have been published by the
Society of Cardiovascular Magnetic Resonance (65). Myocardial
T1 mapping is a rapidly evolving technique, nowwith longitudinal
prognostic data emerging, and normal ranges established at 1.5
and 3.0 T in healthy humans and in aging. Further questions
remain as to the standardization of pulse sequences across field
strengths and between vendors, the affect of contrast type, dose
and timing, the post-processing software, and the interpretation
of T1 mapping results to inform clinical practice.
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